Anti-inflammatory Drugs Flashcards

1
Q

5 main chategories of Anti-inflammatory

A

i. Corticosteroids
ii. Nonsteroidal anti-inflammatory drugs (NSAIDs)
iii. Antihistamines
iv. Leukotriene inhibitors
v. Disease-modifying antirheumatic drugs (DMARDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prevent or limit inflammation by slowing or stopping all known pathways (Prostaglandins, Leukotrienes) of inflammatory mediator production

A

corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Parenteral corticosteriod

A

Methyprednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intended response of corticosteroids

A

i. Reduced redness, pain, swelling at site of inflammation; increased function of affected area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adrenal gland suppression, reduced immune function, delayed wound healing, “Cushingoid appearance”

A

Long term therapy for corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Short term corticosteriods

A

hypertension, acne, insomnia, nervousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

(corticosteroids) Assess for contraindications to adrenal drugs

also what levels?

A

peptic ulcer disease

glucose levels-may alter serum glucose & electrolyte levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

l. Sudden discontinuation of these drugs (glucocorticoid therapy) can precipitate

A

Adrenal crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Caution pts (corticosteroids)

A

w hypertension, hypothyroidism, diabetes mellitus, osteoporosis or liver disease (cautiously)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

i. Fungal infection
ii. Seizure disorder
iii. Ulcerative colitis
iv. Coagulopathy

A

contraindications for corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Because of the risk for hypokalemia, there is an increased risk of dysrhythmias caused by

A

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NSAIDs used to relieve:

A

i. Mild to moderate headaches
ii. Myalgia (muscle pain)
iii. Neuralgia (nerve pain)
iv. Arthralgia (muscle pain)
v. Alleviation of postoperative pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA NSAIDS

A

i. Inhibition of the leukotriene pathway, the prostaglandin pathway, or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

promote synthesis, keeping GI lining intact

A

prostaglandin pathway COX 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

synthesis throughout the body

A

COX 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

check after NSAID

A

i. Bleeding, even with one dose

ii. Sensitivity reaction

17
Q

Patient teaching NSAID

A

ii. Monitor for bleeding

iii. Do not take with warfarin (Coumadin)

18
Q

known aspirin allergy aka

A

can’t take NSAID

19
Q

Conditions that put pts at risk for bleeding:

A

i. Vitamin K deficiency

ii. Peptic ulcer disease

20
Q

NSAID adverse effect

A

a. GI: heartburn to severe GI bleeding
h. Tinnitus, hearing loss
b. Acute renal failure
c. Noncardiogenic pulmonary edema
d. Increased risk of MI and stroke
e. Altered hemostasis
f. Hepatotoxicity
g. Skin eruption, sensitivity reaction

21
Q

Disruption of prostaglandin function by NSAIDs is sometimes strong enough to

A

precipitate acute or chronic renal failure

22
Q

Renal toxicity can occur in patients with

A

dehydration, heart failure, liver dysfunction, or use of diuretics or angiotensin-converting enzyme (ACE) inhibitors

23
Q

COX 1 & 2 examples

A

ibuprofen

24
Q

in the management of RA, OA, primary dysmenorrhea, gout, dental pain, musculoskeletal disorders, antipyretic actions

A

NSAIDS

25
Q

i. Irreversible inhibitor of COX-1 receptors within the platelets themselves
ii. Other NSAIDs lack these antiplatelet effects
iii. Inhibits platelet aggregation

A

Salicylic acid (aspirin)*

26
Q

used in the treatment of MI and other thromboembolic disorders

A

Antithrombotic effect (asprin)

27
Q

i. First and only remaining COX-2 inhibitor

A

Celecoxib (Celebrex)

28
Q

ii. Indicated for OA, RA, acute pain symptoms, ankylosing spondylitis, and primary dysmenorrhea

A

Celecoxib (celebrex)

29
Q

include headache, sinus irritation, diarrhea, fatigue, dizziness, lower extremity edema, and hypertension

A

adverse effects of COX 2

30
Q

a. All NSAIDs (except aspirin) share a black box warning regarding an increased risk of

A

Adverse cardiovascular thrombotic events (MI & stroke)

31
Q

a. Reduce inflammation by preventing inflammatory mediator (usually histamine or leukotriene) from binding to its receptor

A

Antihistamines

32
Q

i. Avoid if they have glaucoma, high blood pressure, prostate enlargement

A

antihistamines

33
Q

i. Blood vessels do not dilate; reduced swelling; mucus, other nasal, eye, respiratory secretions are reduced; narrowed airways widen; hives decrease in size, itchiness

A

intended responses of antihistamines

34
Q

i. Sleepiness, dry mouth, blurred vision, tachycardia, urinary retention

A

side effects of antihistamines

35
Q

b. Diphenhydramine- Oral, IV, IM

A

Benadryl